|

The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients

RECRUITINGSponsored by Beni-Suef University
Actively Recruiting
SponsorBeni-Suef University
Started2025-01-01
Est. completion2026-06-01
Eligibility
Age55 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07244770

Summary

The study aims to investigate the effects of DPP-4 Is+ metformin versus SGLT2 Is + metformin on the risk of cognitive decline and depression in patients with T2DM.

Eligibility

Age: 55 Years+Healthy volunteers accepted
Inclusion Criteria:

\-

The study participants should meet the following inclusion criteria:

1. T2DM adult subjects (\>55 years old) will be eligible to participate.
2. Patients should be taking SGLT2Is+metformin or DDP4Is + metformin for at least 1 year to be eligible.

Exclusion Criteria:

1- Those with type1 diabetes or ketoacidosis, insulin therapy, end organ failure as chronic renal failure, liver, and heart failure, previous history of pancreatitis, history of Alzheimer's disease or any brain insult, and finally pregnant or lactating females will be excluded from the study.

Conditions2

DepressionMCI

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.